Literature DB >> 8712806

Diagnosis and management of nonfunctioning pituitary tumors.

Y Greenman1, S Melmed.   

Abstract

It is now recognized that most clinically nonfunctioning pituitary tumors express gonadotropin hormones or their subunits in vitro, and sometimes in vivo. Many of these tumors are diagnosed by sensitive imaging techniques while patients are still asymptomatic. We outline an overview of the diagnosis and clinical management of these tumors.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8712806     DOI： 10.1146/annurev.med.47.1.95

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN： 0066-4219            Impact factor:   13.739


  15 in total

1.  Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas.

Authors:  T Chile; M L Corrêa-Giannella; M A H Z Fortes; M D Bronstein; M B Cunha-Neto; D Giannella-Neto; R R Giorgi
Journal:  J Endocrinol Invest       Date:  2011-01-26       Impact factor: 4.256

2.  Short-term treatment with cabergoline can lead to tumor shrinkage in patients with nonfunctioning pituitary adenomas.

Authors:  Erica C Garcia; Luciana A Naves; Arthur O Silva; Lucas F de Castro; Luiz A Casulari; Monalisa F Azevedo
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

Review 3.  Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas.

Authors:  Georgia Ntali; John A Wass
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

4.  Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) and guanylate kinase 1 (GUK1) are differentially expressed in GH-secreting adenomas.

Authors:  Anderson Alves da Rocha; Ricardo Rodrigues Giorgi; Sandra Valeria de Sa; Maria Lucia Correa-Giannella; Maria Angela Fortes; Ana Mercedes Cavaleiro; Marcio Carlos Machado; Valter Angelo Cescato; Marcello Delano Bronstein; Daniel Giannella-Neto
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

5.  A Postnatal Pax7 Progenitor Gives Rise to Pituitary Adenomas.

Authors:  Tohru Hosoyama; Koichi Nishijo; Melinda M Garcia; Beverly S Schaffer; Sachiko Ohshima-Hosoyama; Suresh I Prajapati; Michael D Davis; Wilmon F Grant; Bernd W Scheithauer; Daniel L Marks; Brian P Rubin; Charles Keller
Journal:  Genes Cancer       Date:  2010-04-01

6.  Suberoylanilide hydroxamic acid (SAHA) induces growth arrest and apoptosis in pituitary adenoma cells.

Authors:  S R Sangeetha; Nagendra Singh; John R Vender; Krishnan M Dhandapani
Journal:  Endocrine       Date:  2009-03-17       Impact factor: 3.633

Review 7.  Radiotherapy of nonfunctioning and gonadotroph adenomas.

Authors:  Andrew A Kanner; Benjamin W Corn; Yona Greenman
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 8.  Novel pituitary ligands: peroxisome proliferator activating receptor-gamma.

Authors:  Anthony P Heaney
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

9.  Isolation of tumour stem-like cells from benign tumours.

Authors:  Q Xu; X Yuan; P Tunici; G Liu; X Fan; M Xu; J Hu; J Y Hwang; D L Farkas; K L Black; J S Yu
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

10.  Minor tumour shrinkage in nonfunctioning pituitary adenomas by long-term treatment with the dopamine agonist cabergoline.

Authors:  T Lohmann; C Trantakis; M Biesold; S Prothmann; S Guenzel; R Schober; R Paschke
Journal:  Pituitary       Date:  2001-08       Impact factor: 4.107
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.